₹ 1.1 Cr
Volume Transacted
(Nov 7, 2024)
3.6 K
Stocks Traded
(Nov 7, 2024)
Last Updated on: Nov 08, 2024
Ajanta Pharma Ltd
NSE: AJANTPHARM
EPS
₹ 70.05
Last updated on: Nov 07, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Ajanta Pharma Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 37,283 Cr
EPS
₹ 70.1
P/E Ratio (TTM) *
42.6
P/B Ratio (TTM) *
10.1
Day’s High *
3144.75
Day’s Low
₹ 2971.55
DTE *
0.0
ROE *
23.8
52 Week High
₹ 3485.75
52 Week Low
₹ 1783.05
ROCE *
32.1
* All values are consolidated
Last Updated time: 08 Nov 9.00 AM
* All values are consolidated
Last Updated time: 08 Nov 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
07 Nov 2024 | 2984.75 | 3144.75 | 3144.75 | 2971.55 |
06 Nov 2024 | 3120.15 | 3104.05 | 3142.35 | 3075.5 |
05 Nov 2024 | 3110.4 | 3015 | 3125 | 3005.55 |
04 Nov 2024 | 2996.25 | 3147.9 | 3147.9 | 2963.9 |
01 Nov 2024 | 3079.15 | 3068.05 | 3126.45 | 3065 |
31 Oct 2024 | 3071.85 | 3015 | 3177.2 | 3010 |
30 Oct 2024 | 2994.1 | 2924.3 | 3038.75 | 2924.3 |
29 Oct 2024 | 2925 | 2953.25 | 2978.65 | 2880.05 |
28 Oct 2024 | 2921.1 | 2952.2 | 2980.7 | 2904.05 |
25 Oct 2024 | 2970.9 | 2975 | 3027.85 | 2956.55 |
Date | Price (₹) |
---|---|
07 Nov 2024 | 2984.75 |
06 Nov 2024 | 3120.15 |
05 Nov 2024 | 3110.4 |
04 Nov 2024 | 2996.25 |
01 Nov 2024 | 3079.15 |
31 Oct 2024 | 3071.85 |
30 Oct 2024 | 2994.1 |
29 Oct 2024 | 2925 |
28 Oct 2024 | 2921.1 |
25 Oct 2024 | 2970.9 |
Strength
3
S
Weakness
2
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 37,283
Asset Value
₹ 2,570
13.5 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Ajanta Pharma Ltd | 70 | 37,283 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,29,841 |
Divis Laboratories Ltd | 63 | 1,58,179 |
Cipla Ltd | 57 | 1,27,063 |
Mankind Pharma Ltd | 52 | 1,09,234 |
Dr Reddys Laboratories Ltd | 63 | 1,07,398 |
Historical Market Cap of Ajanta Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Ajanta Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Ajanta Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Ajanta Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Ajanta Pharma Ltd spurts 2.75%, rises for third straight session
Ajanta Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 3079...
31 Oct 202413:05
Ajanta Pharma gains after Q2 PAT jumps 11% YoY to Rs 216 cr; declares dividend of Rs 28/ share
Profit before tax gained 5.18% YoY to Rs 290.24 crore in Q2 FY25. EBITDA stood at Rs 311 c...
29 Oct 202412:27
Board of Ajanta Pharma recommends First Interim Dividend
Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on ...
28 Oct 202416:20
Ajanta Pharma Ltd eases for fifth straight session
Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2...
23 Oct 202413:35
Ajanta Pharma to hold board meeting
Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 October 2...
17 Oct 202417:15
Ajanta Pharma hits record high after Q1 PAT rises 19% YoY to Rs 246 cr
Profit before tax increased 19.73% YoY to Rs 322.12 crore in Q1 FY25. EBITDA stood at Rs 3...
30 Jul 202415:46
Concalls
May 2024
TranscriptOct 2023
TranscriptJuly 2023
TranscriptMay 2023
TranscriptAug 2022
TranscriptFeb 2020
PPTMay 2024
TranscriptOct 2023
TranscriptJuly 2023
TranscriptMay 2023
TranscriptAug 2022
TranscriptFeb 2020
PPTFAQs for EPS of Ajanta Pharma Ltd
What is the EPS of Ajanta Pharma Ltd stock?
How is Ajanta Pharma Ltd EPS calculated?
How often does Ajanta Pharma Ltd report its EPS?
What factors can influence Ajanta Pharma Ltd EPS?
Can Ajanta Pharma Ltd EPS growth indicate future performance?
Unlimited trading at just
Rs. 199*